Myelodysplastic syndrome and acute myeloid leukemia as side effect of PARP inhibitors.

3601Background: Acute myeloid leukemia(AML) and myelodysplastic syndrome(MDS) have been rarely noted in patients on PARP inhibitors. The actual incidence is unknown and it has been put has warning/...